HOSPIRA INC 4
4 · HOSPIRA INC · Filed Sep 3, 2015
Insider Transaction Report
Form 4
HOSPIRA INCHSP
Yoskowitz Marc J
SVP, Strategy & Corporate Dev
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2015-09-03−34,570→ 0 totalExercise: $37.36Exp: 2020-06-28→ Common Stock (34,570 underlying) - Award
Common Stock
2015-09-03+3,640→ 47,354 total - Exercise/Conversion
Common Stock
2015-09-03$37.36/sh+34,570$1,291,535→ 81,924 total - Disposition to Issuer
Common Stock
2015-09-03$90.00/sh−110,813$9,973,170→ 0 total - Exercise/Conversion
Common Stock
2015-09-03$42.70/sh+28,889$1,233,560→ 110,813 total - Exercise/Conversion
Stock Options (right to buy)
2015-09-03−28,889→ 0 totalExercise: $42.70Exp: 2021-02-25→ Common Stock (28,889 underlying)
Footnotes (3)
- [F1]Vesting of a performance-contingent restricted stock units award granted June 28, 2013. The units were earned when Hospira's stock price appreciated 20% over the fair market value on the date of grant, and maintained that price for a 30 consecutive trading day period (based on Hospira's closing market price on those 30 consecutive days). Since the units were earned, the award provided for three-year time based cliff vesting, or vesting upon a change of control. Thus, vesting of the units was accelerated upon a change of control.
- [F2]Exercise of stock options granted on 6/28/2013, which vest in four annual installments on June 6, 2014, 2015, 2016 and 2017. The vesting of the last two tranches of options was accelerated in connection with the change of control.
- [F3]Exercise of stock options granted on 2/26/2014, which vest in four annual installments on February 26, 2015, 2016, 2017 and 2018. The vesting of the last three tranches of options was accelerated in connection with the change of control.